These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36675048)

  • 1. C/EBP-Family Redundancy Determines Patient Survival and Lymph Node Involvement in PDAC.
    Hartl L; Roelofs JJTH; Dijk F; Bijlsma MF; Duitman J; Spek CA
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene expression of CCAAT/enhancer-binding protein delta mediated by autoregulation is repressed by related gene family proteins.
    Tanabe A; Kumahara C; Osada S; Nishihara T; Imagawa M
    Biol Pharm Bull; 2000 Dec; 23(12):1424-9. PubMed ID: 11145170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer.
    Hartl L; Ten Brink MS; Aberson HL; Koster J; Zwijnenburg DA; Duitman J; Bijlsma MF; Spek CA
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of mouse chondrocyte differentiation by CCAAT/enhancer-binding proteins.
    Okuma T; Hirata M; Yano F; Mori D; Kawaguchi H; Chung UI; Tanaka S; Saito T
    Biomed Res; 2015; 36(1):21-9. PubMed ID: 25749148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPδ Suppresses Motility-Associated Gene Signatures and Reduces PDAC Cell Migration.
    Hartl L; Maarschalkerweerd PAF; Butler JM; Manz XD; Thijssen VLJL; Bijlsma MF; Duitman J; Spek CA
    Cells; 2022 Oct; 11(21):. PubMed ID: 36359732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C/EBP transcription factors in human squamous cell carcinoma: selective changes in expression of isoforms correlate with the neoplastic state.
    Anand S; Ebner J; Warren CB; Raam MS; Piliang M; Billings SD; Maytin EV
    PLoS One; 2014; 9(11):e112073. PubMed ID: 25402211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
    Duitman J; Hartl L; Roelofs JJTH; Bijlsma MF; Spek CA
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-dependent response of CCAAT/enhancer binding proteins following traumatic brain injury in mice.
    Sandhir R; Berman NE
    Neurochem Int; 2010 Jan; 56(1):188-93. PubMed ID: 19833158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the CCAAT/enhancer-binding proteins C/EBPalpha, C/EBPbeta and C/EBPdelta in breast cancer: correlations with clinicopathologic parameters and cell-cycle regulatory proteins.
    Milde-Langosch K; Löning T; Bamberger AM
    Breast Cancer Res Treat; 2003 May; 79(2):175-85. PubMed ID: 12825852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCAAT/enhancer-binding protein delta activates the Runx2-mediated transcription of mouse osteocalcin II promoter.
    Shin CS; Jeon MJ; Yang JY; Her SJ; Kim D; Kim SW; Kim SY
    J Mol Endocrinol; 2006 Jun; 36(3):531-46. PubMed ID: 16720721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1.
    Huang CS; Chu J; Zhu XX; Li JH; Huang XT; Cai JP; Zhao W; Yin XY
    Cancer Lett; 2018 May; 421():63-72. PubMed ID: 29458145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.
    Hartl L; Duitman J; Aberson HL; Chen K; Dijk F; Roelofs JJTH; Dings MPG; Hooijer GKJ; Hernanda PY; Pan Q; Busch OR; Besselink MGH; Boerman T; Peppelenbosch MP; Bijlsma MF; Spek CA
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32906832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide.
    Ramberg V; Tracy LM; Samuelsson M; Nilsson LN; Iverfeldt K
    J Neuroinflammation; 2011 Apr; 8():34. PubMed ID: 21492414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP).
    Parkin SE; Baer M; Copeland TD; Schwartz RC; Johnson PF
    J Biol Chem; 2002 Jun; 277(26):23563-72. PubMed ID: 11980905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of aromatase P450 expression in endometriotic and endometrial stromal cells by CCAAT/enhancer binding proteins (C/EBPs): decreased C/EBPbeta in endometriosis is associated with overexpression of aromatase.
    Yang S; Fang Z; Suzuki T; Sasano H; Zhou J; Gurates B; Tamura M; Ferrer K; Bulun S
    J Clin Endocrinol Metab; 2002 May; 87(5):2336-45. PubMed ID: 11994385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A MicroRNA Signature Identifies Pancreatic Ductal Adenocarcinoma Patients at Risk for Lymph Node Metastases.
    Nishiwada S; Sho M; Banwait JK; Yamamura K; Akahori T; Nakamura K; Baba H; Goel A
    Gastroenterology; 2020 Aug; 159(2):562-574. PubMed ID: 32376411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transforming growth factor-beta inhibits adipocyte differentiation by Smad3 interacting with CCAAT/enhancer-binding protein (C/EBP) and repressing C/EBP transactivation function.
    Choy L; Derynck R
    J Biol Chem; 2003 Mar; 278(11):9609-19. PubMed ID: 12524424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPγ is a critical negative regulator of LPS-/IgG immune complex-induced acute lung injury through the downregulation of C/EBPβ-/C/EBPδ-dependent C/EBP transcription activation.
    Yan C; Zhang L; Yang L; Zhang Q; Wang X
    FASEB J; 2020 Oct; 34(10):13696-13710. PubMed ID: 32786052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCAAT/enhancer binding protein δ is a transcriptional repressor of α-synuclein.
    Valente T; Dentesano G; Ezquerra M; Fernandez-Santiago R; Martinez-Martin J; Gallastegui E; Domuro C; Compta Y; Martí MJ; Bachs O; Márquez-Kisinousky L; Straccia M; Solà C; Saura J
    Cell Death Differ; 2020 Feb; 27(2):509-524. PubMed ID: 31209363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Janus kinase 1 is critical for pancreatic cancer initiation and progression.
    Shrestha H; Rädler PD; Dennaoui R; Wicker MN; Rajbhandari N; Sun Y; Peck AR; Vistisen K; Triplett AA; Beydoun R; Sterneck E; Saur D; Rui H; Wagner KU
    Cell Rep; 2024 May; 43(5):114202. PubMed ID: 38733583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.